Navigation Links
BioMS Medical Announces 2008 Year End Results
Date:3/17/2009

ge for an $87 million upfront payment, milestone payments and escalating royalties on sales. For further information please visit our website at http://www.biomsmedical.com

This press release may contain forward-looking statements, which reflect the Corporation's current expectation regarding future events. These forward-looking statements involve risks and uncertainties that may cause actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward-looking statements. Such factors include, but are not limited to, changing market conditions, the successful and timely completion of clinical studies, the establishment of corporate alliances, the impact of competitive products and pricing, new product development, uncertainties related to the regulatory approval process and other risks detailed from time to time in the Corporation's ongoing quarterly and annual reporting. Certain of the assumptions made in preparing forward-looking statements include but are not limited to the following: that dirucotide will continue to demonstrate a satisfactory safety profile in ongoing and future clinical trials; and that BioMS Medical Corp. will complete the respective clinical trials within the timelines communicated in this release. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

    BioMS Medical Corp.
    (A Development Stage Corporation)
    Consolidated Balance Sheet
    December 31, 2008 and 2007
    -------------------------------------------------------------------------

    (expressed in thousands of Canadian dollars)

                                                             2008       2007
                                                                $          $

'/>"/>
SOURCE  BioMS Medical Corp.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 

Related biology technology :

1. BioMS Medical warrant extension
2. BioMS Medical to present at BIO CEO and Investor Conference
3. BioMS Medical reports results of exploratory phase II trial of dirucotide in relapsing remitting multiple sclerosis
4. BioMS Medical recognized at Scrip Awards 2008
5. BioMS Medical Announces Third Quarter 2008 Results
6. BioMS Medical to present at Rodman and Renshaw Annual Healthcare Conference
7. BioMS Medicals relapsing-remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board
8. BioMS Medicals phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board
9. BioMS Medical announces receipt of milestone payment from Eli Lilly and Company
10. BioMS Medical to present at Sachs Associates Biotech in Europe Forum
11. BioMS Medical to present at UBS Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... and TEL AVIV, Israel , ... or the "Company") (NYSE MKT: NSPR), a leader in embolic ... the Company,s President and Chief Executive Officer, and ... participate in the Benchmark Company, LLC One-on-One Investor Conference on ... Wisconsin Ave., Milwaukee, WI. ...
(Date:5/24/2013)... 2013 This market report summarizes ... profiling carried out in May 2013. The full ... of the responses for each question, its segmentation ... also highlights some interesting differences, particularly between Pharma, ... models were developed to estimate the in house ...
(Date:5/24/2013)... The Oklahoma tornado left the ... the mayor of Moore, one of the heavily damaged towns, ... report from cnn.com. Reaching out to also be of help, ... Safe Shield to counter the looming mold problem. , The ... 22, 2013, caused 24 deaths, My Cleaning Products shared. Ten ...
(Date:5/24/2013)... 2013 Quincy Bioscience, a leading ... of calcium-binding proteins to support healthy living, is ... study of apoaequorin in Food and ... the British Industrial Biological Research Association. , ... potential adverse effects, if any, of apoaequorin, in ...
Breaking Biology Technology:InspireMD To Participate In Benchmark Investor Conference On May 30th 2InspireMD To Participate In Benchmark Investor Conference On May 30th 3InspireMD To Participate In Benchmark Investor Conference On May 30th 4Kinase Market Profiling - In House & Outsourced Trends 2015 Forecast in New Research Report at ReportsnReports.com 2Kinase Market Profiling - In House & Outsourced Trends 2015 Forecast in New Research Report at ReportsnReports.com 3Kinase Market Profiling - In House & Outsourced Trends 2015 Forecast in New Research Report at ReportsnReports.com 4Mayor of Oklahoma-Tornado-Impaired Town Proposes Storm Shelter Bill, My Cleaning Products Offers Complimentary Molderizer and Safe Shield to Help Victim with Looming Mold 2Safety Assessment Study of Apoaequorin Published in Food and Chemical Toxicology 2
... May 5 On Thursday, May 8, 2008, ... members of,Cell Therapeutics, Inc.,s (CTI) (Nasdaq: CTIC ... call to discuss the company,s 2008 first,quarter achievements ... Thursday, May 8 8:30 a.m. Eastern/2:30 ...
... the lines, dots and other shapes etched on them ... found a way to literally melt away such defects, ... without increasing fabrication cost. , The method, published in ... precise shaping of microchip components than what is possible ...
... Inc. (OTC Bulletin Board: MCET) has moved into new space ... 1, 2008:, -- the new address is: 68 ... 02895. -- new phone number is: (401) ... 762-0098, MultiCell Technologies, Inc. is a biopharmaceutical company developing,new ...
Cached Biology Technology:Melting defects could lead to smaller, more powerful microchips 2Melting defects could lead to smaller, more powerful microchips 3Melting defects could lead to smaller, more powerful microchips 4MultiCell Technologies Relocates Corporate Headquarters 2
(Date:5/23/2013)... Wis. In an age when microbial pathogens are ... tamp down infection, a team of Wisconsin scientists has ... curbing the bacteria that cause staph infections. , Writing ... Society , a group led by University of Wisconsin-Madison ... with the "quorum sensing" behavior of Staphylococcus aureus ...
(Date:5/22/2013)... engineers must join together in a major new effort ... crisis in providing Earth,s people with clean water that ... of a comment article in the current edition of ... of the American Chemical Society (ACS), the world,s largest ... Sedlak, Ph.D., and Jerald L. Schnoor, Ph.D., explain that ...
(Date:5/22/2013)... bacteria is responsible for legionellosis, an infectious disease ... us, this pathogen has developed a complex method enabling ... cells, thus avoiding these acting against the infectious bacteria. ... CIC bioGUNE, in which teams from the National Institute ... Supercomputation Centre in Barcelona (BSC) have also participated, has ...
Breaking Biology News(10 mins):University of Wisconsin chemists find new compounds to curb staph infection 2Mechanism discovered which aids Legionella to camouflage itself in the organism 2
... Nov. 1, 2007) This months issue ... www.cshprotocols.org ) features a cutting-edge method that provides ... mixed populations of cells. The protocol is ... by Ingrid Schmid, a scientist at UCLA ( ...
... have identified a new way to breed brassicas, which ... damaging virus. Their discovery has characterised a form of ... to be overcome by the virus over time. Turnip ... infects a wide range of cultivated plants, but especially ...
... contribute as much as vehicles to carbon emissions in ... New research published in the online open access journal ... fires will complicate emissions monitoring and modelling efforts. ... and Jason Neff of the University of Colorado, both ...
Cached Biology News:Genes identified to protect brassicas from damaging disease 2US faces burning emissions issue 2
Rabbit polyclonal to QKI...
... Mass Spectrometry Applications ,In the age ... emerged as a powerful protein identification and ... is now an important intermediate step in ... to identification of specific proteins in the ...
... ammonium sulfate are compatible with thermostable enzymes ... and AmpliThem™™ DNA polymerases. You can significantly ... one experiment by adding your own enzyme, ... supplied with the kit. This capability is ...
... MasterAmp™ PCR Optimization Kits without ammonium sulfate ... in PCR, such as Taq and AmpliThem™™ ... performance of PCR systems in one experiment ... PCR primers into the PreMixes supplied with ...
Biology Products: